Coronary Artery Bypass Grafting
Pipeline by Development Stage
Coronary Artery Bypass Grafting is a surgical indication with limited oral pharmaceutical market presence, characterized by procedural dominance rather than drug-driven revenue.
Key Trends
- Clinical pipeline dominated by perioperative support and graft patency agents
- Bristol Myers Squibb concentration signals niche specialization opportunity
- Phase 3/4 trials indicate mature development stage with regulatory clarity
Career Verdict
This is a specialized, lower-volume pharmaceutical niche—better suited for professionals seeking deep clinical expertise in cardiac surgery support rather than broad commercial exposure.
AI-generated market analysis based on FDA, CMS, ClinicalTrials.gov, and hiring data
Career Outlook
StableThe CABG pharmaceutical market is a mature, niche segment within cardiac surgery—not expanding rapidly but offering deep expertise opportunities in perioperative care and graft optimization. Career growth will be incremental rather than explosive, with most openings concentrated in manufacturing and operational roles. This is a "specialist's" space: high barriers to entry but stable, predictable careers for those with cardiac or surgical pharmacy backgrounds.
Breaking In
Enter through manufacturing, quality assurance, or clinical operations—these roles have the highest hiring volume and lowest specialist barriers; build cardiac surgery knowledge on the job.
For Experienced Professionals
If you have cardiac surgery, cardiovascular pharmacology, or Phase 3/4 trial leadership experience, you have a valuable niche; otherwise, view this as a deep-dive specialization rather than a high-growth career accelerator.
In-Demand Skills
Best For
Hiring Landscape
Bristol Myers Squibb anchors 760 job openings in CABG-related roles, with manufacturing (38%) and medical affairs (10%) dominating demand. Clinical Operations roles command the highest salaries ($283K avg), reflecting the specialized nature of cardiac surgical support. This concentration in one company indicates that CABG specialization carries significant single-employer risk.
Top Hiring Companies
By Department
Manufacturing and supply chain roles dominate; pharma professionals with operations or quality backgrounds have the strongest entry point, but diversification beyond Bristol Myers Squibb is essential for career resilience.
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (4)
Total enrollment: 1,680 patients across 4 trials
Sealing Moderate Coronary Saphenous VEin Graft Lesions With Paclitaxel-Eluting Stents
Treatment of Moderate Vein Graft Lesions With Paclitaxel Drug Eluting Stents: The VELETI Trial
Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass
Arrested Versus Beating Heart Techniques in Coronary Revascularisation
Related Jobs in Cardiovascular
AI & Digital Lead M/F/X
Senior Clinical Research Associate - Cardiovascular (EDG-2026033)
Executive Director, Head of Global Site Management
Director, Clinical Trial Liaison - Northern Midwest: Illinois; Indiana; Michigan; Minnesota; Missouri; Iowa; North Dakota
Executive Director, Data, AI & Collaboration Services
Territory Manager- PV - Los Angeles Proper
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.